20 mg/g, cream
Fusidic acid
Fucidin is a cream for topical use. The active substance of the medicine is fusidic acid - an antibiotic with antibacterial action. Fusidic acid acts on some Gram-positive bacteria. Staphylococci are particularly sensitive to the action of fusidic acid.
Fucidin cream is indicated for the topical treatment of bacterial skin infections caused by bacteria sensitive to fusidic acid. The primary indications are:
impetigo, folliculitis, furunculosis, sycosis, paronychia, and acne vulgaris.
Avoid contact of the medicine with the eyes and mucous membranes, as it may cause irritation of the conjunctiva and mucous membranes.
No data available.
Tell your doctor or pharmacist about all medicines you are taking, or have recently taken, and any medicines you plan to take.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, consult your doctor before using this medicine.
During breastfeeding, do not apply Fucidin cream to the breast.
Fucidin cream has no influence or insignificant influence on the ability to drive and use machines, as well as on psychophysical fitness.
Fucidin cream contains butylhydroxyanisole, cetyl alcohol, and potassium sorbate, which may cause local skin reactions (e.g., contact dermatitis).
Butylhydroxyanisole in the medicine may also cause eye and mucous membrane irritation.
Always use this medicine exactly as your doctor has told you. If you are not sure, consult your doctor or pharmacist.
The medicine is intended for topical use on the skin.
Usually, apply the medicine to the affected areas of skin 2 to 3 times a day for 7 days.
No cases of overdose have been reported when using the medicine according to the indications and recommended use.
If you feel unwell after taking more than the recommended dose, contact your doctor.
Do not take a double dose to make up for a forgotten dose.
Continue treatment according to the previously established schedule.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Severe side effects (in 1 patient in 1000) may occur, such as skin and mucous membrane swelling of the face, mouth, and throat. If these occur, contact your doctor immediately.
Other side effects include:
If you experience any side effects, including any side effects not listed in the leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of the medicine.
Store below 25°C.
Keep the medicine out of the sight and reach of children.
Do not use the medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Available packs:
An aluminum tube containing 15 g of cream, placed in a cardboard box.
For more detailed information, contact the marketing authorization holder or parallel importer.
LEO Pharma A/S
Industriparken 55
2750 Ballerup
Denmark
LEO Laboratories Ltd.
285 Cashel Road
Dublin 12
Ireland
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in the Czech Republic, the country of export:46/319/97-C
Parallel import authorization number:107/17
Date of leaflet approval: 28.03.2022
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.